Melodiol Global Health Limited (ME1.AX)

0.0030 +0.0010 (+50.00%) At close: 03:44PM AEST

Melodiol Global Health Limited

145 Stirling Highway
Suite 5 CPC
Nedlands, WA 6009
Australia
61 8 9389 3180
https://melodiolglobalhealth.com

Sector(s): 
Industry: 
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Boaz Wachtel M.A., M.D., MBA	Co-Founder & Non-Executive Chairman	80k	N/A	1961
Mr. William Lay B.Com.	Group CEO, MD & Director	411.51k	N/A	N/A
Mr. Christopher Grundy BCom, FCA, FCIS, GAICD	Chief Financial Officer	333.01k	N/A	N/A
Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.	Executive Director	237.82k	N/A	N/A
Dr. Gian Trepp	Commercial & Marketing Director	N/A	N/A	N/A
Mr. Mitchel Fleming	Managing Director of Halucenex	N/A	N/A	N/A
Brett Ayers	Managing Director of Impactive	N/A	N/A	N/A
Mr. Winton William Willesee C.P.A., GAICD, MAICD, MCom	Joint Company Secretary	N/A	N/A	1970
Hon. Brian Walker	Strategic Consultant & Chair of Scientific Advisory Committee	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Melodiol Global Health Limited engages in the development, cultivation, and distribution of recreational and medical cannabis products in Europe, Canada, Australia, and the Asia Pacific. It is involved in the development and commercialisation of nutraceutical products; and medical supplies business. The company was formerly known as Creso Pharma Limited and changed its name to Melodiol Global Health Limited in June 2023. Melodiol Global Health Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Corporate governance

Melodiol Global Health Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.